Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1000 of 1467 entries
View as:

Mechanistic Study of the Effect of Itepekimab on Airway Inflammation in Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT05326412 Org: User:
Start: 05/19/22 End: 07/23/25 Due: 07/23/26

A Study to Evaluate Absolute Bioavailability, Absorption, Metabolism, and Excretion of Genz-112638 in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT06143904 Org: User:
Start: 06/03/09 End: 07/05/09 Due: 07/05/10

Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00012389 Org: User:
Start: 12/31/00 End: 10/31/08 Due: 10/31/09

Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Mild Hepatic Impairment Compared to Participants With Normal Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT05283915 Org: User:
Start: 03/18/22 End: 05/24/22 Due: 05/24/23

Study of AVE1642 Anti-IGF1R Monoclonal Antibody in Patients With Advanced Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01233895 Org: User:
Start: 09/30/06 End: 09/30/08 Due: 09/30/09

A Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00925743 Org: User:
Start: 06/30/09 End: 03/31/13 Due: 03/31/14

APROVE : Irbesartan in Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00283036 Org: User:
Start: 04/30/05 End: - Due: -

Evaluation of SAR408701 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02187848 Org: User:
Start: 07/23/14 End: 11/19/24 Due: 11/19/25

An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00577148 Org: User:
Start: 02/29/08 End: 02/28/09 Due: 02/28/10

A Study to Investigate Natural Killer Cell Engager (SAR443579) With Different Agents in Participants With Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT06508489 Org: User:
Start: 08/13/24 End: 08/13/29 Due: 08/13/30

Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00596206 Org: User:
Start: 12/31/07 End: 10/31/09 Due: 10/31/10

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants With Achondroplasia

Phase: N/A Priority: Normal
NCT ID: NCT06067425 Org: User:
Start: 10/10/23 End: 02/12/25 Due: 02/12/26

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01403636 Org: User:
Start: 10/31/11 End: 09/30/14 Due: 09/30/15

Evaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5×10^6CD34+ Cells/kg in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT01767714 Org: User:
Start: 04/30/13 End: 11/30/14 Due: 11/30/15

To Assess the Glycosphingolipid Clearance and Clinical Effects of Switching to Agalsidase Beta (Fabrazyme) Versus Continuing on Agalsidase Alfa (Replagal) in Male Patients With Classic Fabry Disease

Phase: N/A Priority: Normal
NCT ID: NCT04143958 Org: User:
Start: 09/30/20 End: 11/30/23 Due: 11/30/24

Study of Live Attenuated ChimeriVax™-Japanese Encephalitis Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00981630 Org: User:
Start: 11/30/04 End: 11/30/07 Due: 11/30/08

Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00401323 Org: User:
Start: 01/31/98 End: 06/30/03 Due: 06/30/04

Study to Investigate the Clinical and Parasiticidal Activity and Pharmacokinetics of Different Doses of Artefenomel and Ferroquine in Patients With Uncomplicated Plasmodium Falciparum Malaria

Phase: N/A Priority: Normal
NCT ID: NCT03660839 Org: User:
Start: 09/11/18 End: 11/06/19 Due: 11/06/20

Safety Evaluation of Clopidogrel Sulfate in Patients With Stable Angina/Old Myocardial Infarction to Whom Percutaneous Coronary Intervention is Being Planned

Phase: N/A Priority: Normal
NCT ID: NCT00821834 Org: User:
Start: 12/31/08 End: 08/31/10 Due: 08/31/11

Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00271284 Org: User:
Start: 10/31/05 End: 09/30/08 Due: 09/30/09

Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00565448 Org: User:
Start: 11/30/07 End: 01/31/12 Due: 01/31/13

Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine

Phase: N/A Priority: Normal
NCT ID: NCT05107115 Org: User:
Start: 11/24/21 End: 04/23/24 Due: 04/23/25

Dose Ranging Study in Elective Total Hip Replacement Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00338897 Org: User:
Start: 05/31/06 End: 05/31/07 Due: 05/31/08

An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Phase: N/A Priority: Normal
NCT ID: NCT00256113 Org: User:
Start: 12/31/04 End: 12/31/06 Due: 12/31/07

Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT06058156 Org: User:
Start: 11/09/23 End: 08/18/26 Due: 08/18/27